Arriving in the arena of weight management treatment, retatrutide represents a different approach. Beyond many existing medications, retatrutide functions as a twin agonist, simultaneously engaging both GLP peptide-1 (GLP-1) and glucose-sensitive insulinotropic substance (GIP) binding sites. The concurrent activation fosters several beneficial effe… Read More